Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New NCCN guidelines explain how to recognize and manage immunotherapy-related toxicities.
Researchers discover 40.2% of advanced cancer patients with unplanned hospitalizations experienced functional impairment.
National Comprehensive Cancer Network guidelines offer expert advice on treatment and prevention.
These guidelines can help minimize exposure risk while also preserving resources for those with the most immediate need for care.
COVID-19 has disrupted care and raised treatment safety concerns. These trustworthy sources can help you stay up to date.
Experts from Seattle Cancer Care Alliance share lessons from early experiences treating people with cancer during the COVID-19 outbreak.
“Young adult survivors are more vulnerable to financial instability for many reasons related to the tasks of young adult development."
A new study points to need for greater efforts to reduce racial disparities in cancer survival and increase access to health care.
NCCN Patient Advocacy Summit examines the patient perspective on delivering value and high-quality care.
Research finds people treated outside of NCCN Guidelines recommendations had significantly higher direct costs.
Researchers from Johns Hopkins Kimmel Cancer Center pilot multidisciplinary approach for addressing immunotherapy-related toxicities.
American Cancer Society study finds patients who were satisfied with communication had better health results at lower cost.
Guidelines for gestational trophoblastic neoplasia help ensure pregnant women with cancer get life-saving treatment and preserve fertility.
African-American women, in particular, are less likely to receive the recommended amount of screening after surgery.
National Comprehensive Cancer Network releases new Guidelines for best practices for treating patients with kaposi sarcoma
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.